UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037529
Receipt number R000042786
Scientific Title An effectiveness confirmation test of test food consumption
Date of disclosure of the study information 2020/07/29
Last modified on 2020/10/09 11:53:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An effectiveness confirmation test of test food consumption

Acronym

An effectiveness confirmation test of test food consumption

Scientific Title

An effectiveness confirmation test of test food consumption

Scientific Title:Acronym

An effectiveness confirmation test of test food consumption

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm effectiveness on blood miRNA in human by consumption of test food.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Level of blood miRNA

Key secondary outcomes

Level of blood total protein
Level of blood albumin
Level of blood AST
Level of blood ALT
Level of blood LDH
Level of blood total bilirubin
Level of blood ALP
Level of blood gamma-GTP
Level of blood CPK
Level of blood BUN
Level of blood CRE
Level of blood UA
Level of blood Na
Level of blood Cl
Level of blood K
Level of blood Ca
Level of blood total cholesterol
Level of blood LDL-cholesterol
Level of blood HDL-cholesterol
Level of blood triglyceride
Level of blood glucose


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intake two tablets of test food which contain pterostilbene for four weeks

Interventions/Control_2

Intake two tablets of test food which contain pterostilbene for four weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

45 years-old <=

Age-upper limit

64 years-old >=

Gender

Male

Key inclusion criteria

1)Males aged 45-64 years at a time of obtaining informed consent.
2)Subjects who show understanding of the clinical study procedures and agreement with participating this study by written informed consent.

Key exclusion criteria

1)Subjects who are currently receiving medication.
2)Subjects who have previous and/or current medical history of serious disease (e.g., heart, liver, kidney, digestive organ).
3)Subjects who have excessive alcohol intake.
4)Subjects who constantly use oral medicines, Food for Specified Health Uses (FOSHU), functional foods, supplements and/or healthy foods having a possibility of affecting test results.
5)Subjects who have extremely irregular dietary habits, have midnight work or irregular shift work.
6)Subjects who have allergy to medicines or foods (especially gelatin).
7)Subjects who are participating the other clinical test, were participating it within the past 4 weeks, or are going to participate it.
8)Subjects who donated over 200mL blood and/or blood components within the last one month to the current study.
9)Subjects who donated over 400mL blood and/or blood components within the last three month to the current study.
10)Subjects who is going to be collected over 1200mL blood and/or blood components which is collected whithin the last 12 month and at this study
11)Subjects judged as unsuitable for the study by the principal or attending investigator.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Shukuko
Middle name
Last name Ebihara

Organization

Chiyoda Paramedical Care Clinic

Division name

Director

Zip code

101-0047

Address

2F Sanwauchikanda Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, JAPAN

TEL

03-5297-5548

Email

cpcc-contact@cpcc.co.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Kuriki

Organization

Kewpie Corporation

Division name

Evaluation & Analysis Sciences Department Institute of Technology Solutions, R&D Division

Zip code

182-0002

Address

2-5-7, Sengawa-Cho, Chofu-Shi, Tokyo 182-0002, Japan.

TEL

03-5384-7759

Homepage URL


Email

daisuke_kuriki@kewpie.co.jp


Sponsor or person

Institute

Kewpie Corporation

Institute

Department

Personal name



Funding Source

Organization

Kewpie Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Chiyoda Paramedical Care Clinic

Address

2F Sanwauchikannda Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, Japan

Tel

03-5297-5548

Email

IRB@cpcc.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

100

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 07 Month 21 Day

Date of IRB

2019 Year 07 Month 19 Day

Anticipated trial start date

2019 Year 07 Month 30 Day

Last follow-up date

2019 Year 11 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 07 Month 29 Day

Last modified on

2020 Year 10 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042786


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name